Where do Nurix Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Nurix Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	-439.3%-30.4pp	-340.2%+50.4pp	-319.3%+24.0pp	-260.8%+26.7pp	-408.9%-214pp
Net margin	-411.4%-42.0pp	-314.9%+39.9pp	-292.5%+21.2pp	-234.6%+30.3pp	-369.4%-190pp
Returns
Return on equity	-61.4%+2.8pp	-49.6%+3.6pp	-65.4%-7.4pp	-50.7%+1.7pp	-64.2%+1.2pp
Return on invested capital	-70.2%+9.6pp	-72.2%-3.5pp	-81.8%-4.7pp	-66.2%+6.6pp	-79.8%-0.8pp
Efficiency
Asset turnover	0.1×0.0×	0.1×0.0×	0.2×0.0×	0.2×0.0×	0.1×-0.1×
Liquidity
Current ratio	6×-0.3×	7×+0.6×	5.4×+0.1×	6.8×+1.2×	6.3×+3.4×
Leverage
Debt-to-equity	0.1×+0.1×	0.1×0.0×	0.2×+0.1×	0.1×0.0×	0.1×-0.1×
Per Share
Book value per share	$4.37-24.1%	$6.22-20.8%	$4.42-14.6%	$5.34-10.2%	$5.76+87.3%
Valuation
Market capitalization	$1.64B+40.1%	$1.79B+11.4%	$714.04M-61.1%	$744.82M-35.0%	$1.17B+52.2%
Price / sales	22.9×+2.1×	21.3×-8.2×	8.5×-24.0×	8.4×-10.0×	20.8×+11.3×
Price / book	3.4×+1.0×	3.3×+0.3×	1.9×-2.9×	1.7×-1.4×	2.4×-2.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Nurix Therapeutics, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Nurix Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Nurix Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.